Organon & Co (OGN) — Strategic Asset Allocation Index
Organon & Co (OGN) has a Strategic Asset Allocation Index of 193.9% as of December 2025. Strategic assets (PP&E of $1.46 Billion plus long-term investments of $-) total $1.46 Billion, measured against net assets of $752.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Organon & Co balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Organon & Co Strategic Asset Allocation Index (2018–2025)
This chart shows how Organon & Co's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2025. As of December 2025, the index stands at 193.9%, representing strategic assets of $1.46 Billion against net assets of $752.00 Million USD. For live market cap and overall valuation, see market cap of Organon & Co.
Annual Strategic Asset Allocation Index for Organon & Co (2018–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Organon & Co from 2018 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See OGN total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 193.9% | $1.46 Billion | $1.46 Billion | $- | $752.00 Million | ▼ -86.8 pp |
| 2024 | 280.7% | $1.32 Billion | $1.32 Billion | $- | $472.00 Million | ▲ +260.9 pp |
| 2020 | 19.9% | $1.09 Billion | $1.09 Billion | $- | $5.49 Billion | ▲ +9.0 pp |
| 2019 | 10.8% | $762.00 Million | $762.00 Million | $- | $7.04 Billion | ▲ +0.6 pp |
| 2018 | 10.3% | $651.00 Million | $651.00 Million | $- | $6.35 Billion | — |